Carbon monoxide inhibits hemotoxic activity of Elapidae venoms: potential role of heme

Vance G Nielsen, Nathaniel Frank, Ryan W. Matika

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Envenomation by hemotoxic enzymes continues to be a major cause of morbidity and mortality throughout the world. With regard to treatment, the gold standard to abrogate coagulopathy caused by these venoms is still the administration of antivenom; however, despite antivenom therapy, coagulopathy still occurs and recurs. Of interest, this laboratory has demonstrated in vitro and in vivo that coagulopathy inducing venom derived from snakes of the family Viperidae exposed to carbon monoxide (CO) is inhibited, potentially by an attached heme. The present investigation sought to determine if venoms derived from snakes of the Elapidae family (taipans and cobras) could also be inhibited with CO or with the metheme inducing agent, O-phenylhydroxylamine (PHA). Assessing changes in coagulation kinetics of human plasma with thrombelastography, venoms from Elapidae snakes were exposed in isolation to CO (five species) or PHA (one specie) and placed in human plasma to assess changes in procoagulant or anticoagulant activity. The procoagulant activity of two taipan venoms and anticoagulant activity of three cobra venoms were significantly inhibited by CO. The venom of the inland taipan was also inhibited by PHA. In sum, these data demonstrate indirectly that the biometal heme is likely bound to these disparate venoms as an intermediary modulatory molecule. In conclusion, CO may not just be a potential therapeutic agent to treat envenomation but also may be a potential modulator of heme as a protective mechanism for venomous snakes against injury from their own proteolytic venoms.

Original languageEnglish (US)
Pages (from-to)1-9
Number of pages9
JournalBioMetals
DOIs
StateAccepted/In press - Nov 23 2017

Fingerprint

Elapidae
carbon monoxide
Venoms
venoms
heme
Carbon Monoxide
Heme
Carbon monoxide
Snake Venoms
Plasma (human)
Antivenins
snakes
Anticoagulants
antivenoms
anticoagulant activity
Thrombelastography
Cobra Venoms
Snakes
Trace Elements
Viperidae

Keywords

  • Carbon monoxide
  • Cobra
  • Fibrinogenolysis
  • Prothrombin activator
  • Taipan

ASJC Scopus subject areas

  • Biomaterials
  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • Metals and Alloys

Cite this

Carbon monoxide inhibits hemotoxic activity of Elapidae venoms : potential role of heme. / Nielsen, Vance G; Frank, Nathaniel; Matika, Ryan W.

In: BioMetals, 23.11.2017, p. 1-9.

Research output: Contribution to journalArticle

@article{f5ce9526b49744d18fed9437389a84c2,
title = "Carbon monoxide inhibits hemotoxic activity of Elapidae venoms: potential role of heme",
abstract = "Envenomation by hemotoxic enzymes continues to be a major cause of morbidity and mortality throughout the world. With regard to treatment, the gold standard to abrogate coagulopathy caused by these venoms is still the administration of antivenom; however, despite antivenom therapy, coagulopathy still occurs and recurs. Of interest, this laboratory has demonstrated in vitro and in vivo that coagulopathy inducing venom derived from snakes of the family Viperidae exposed to carbon monoxide (CO) is inhibited, potentially by an attached heme. The present investigation sought to determine if venoms derived from snakes of the Elapidae family (taipans and cobras) could also be inhibited with CO or with the metheme inducing agent, O-phenylhydroxylamine (PHA). Assessing changes in coagulation kinetics of human plasma with thrombelastography, venoms from Elapidae snakes were exposed in isolation to CO (five species) or PHA (one specie) and placed in human plasma to assess changes in procoagulant or anticoagulant activity. The procoagulant activity of two taipan venoms and anticoagulant activity of three cobra venoms were significantly inhibited by CO. The venom of the inland taipan was also inhibited by PHA. In sum, these data demonstrate indirectly that the biometal heme is likely bound to these disparate venoms as an intermediary modulatory molecule. In conclusion, CO may not just be a potential therapeutic agent to treat envenomation but also may be a potential modulator of heme as a protective mechanism for venomous snakes against injury from their own proteolytic venoms.",
keywords = "Carbon monoxide, Cobra, Fibrinogenolysis, Prothrombin activator, Taipan",
author = "Nielsen, {Vance G} and Nathaniel Frank and Matika, {Ryan W.}",
year = "2017",
month = "11",
day = "23",
doi = "10.1007/s10534-017-0066-2",
language = "English (US)",
pages = "1--9",
journal = "BioMetals",
issn = "0966-0844",
publisher = "Springer Netherlands",

}

TY - JOUR

T1 - Carbon monoxide inhibits hemotoxic activity of Elapidae venoms

T2 - potential role of heme

AU - Nielsen, Vance G

AU - Frank, Nathaniel

AU - Matika, Ryan W.

PY - 2017/11/23

Y1 - 2017/11/23

N2 - Envenomation by hemotoxic enzymes continues to be a major cause of morbidity and mortality throughout the world. With regard to treatment, the gold standard to abrogate coagulopathy caused by these venoms is still the administration of antivenom; however, despite antivenom therapy, coagulopathy still occurs and recurs. Of interest, this laboratory has demonstrated in vitro and in vivo that coagulopathy inducing venom derived from snakes of the family Viperidae exposed to carbon monoxide (CO) is inhibited, potentially by an attached heme. The present investigation sought to determine if venoms derived from snakes of the Elapidae family (taipans and cobras) could also be inhibited with CO or with the metheme inducing agent, O-phenylhydroxylamine (PHA). Assessing changes in coagulation kinetics of human plasma with thrombelastography, venoms from Elapidae snakes were exposed in isolation to CO (five species) or PHA (one specie) and placed in human plasma to assess changes in procoagulant or anticoagulant activity. The procoagulant activity of two taipan venoms and anticoagulant activity of three cobra venoms were significantly inhibited by CO. The venom of the inland taipan was also inhibited by PHA. In sum, these data demonstrate indirectly that the biometal heme is likely bound to these disparate venoms as an intermediary modulatory molecule. In conclusion, CO may not just be a potential therapeutic agent to treat envenomation but also may be a potential modulator of heme as a protective mechanism for venomous snakes against injury from their own proteolytic venoms.

AB - Envenomation by hemotoxic enzymes continues to be a major cause of morbidity and mortality throughout the world. With regard to treatment, the gold standard to abrogate coagulopathy caused by these venoms is still the administration of antivenom; however, despite antivenom therapy, coagulopathy still occurs and recurs. Of interest, this laboratory has demonstrated in vitro and in vivo that coagulopathy inducing venom derived from snakes of the family Viperidae exposed to carbon monoxide (CO) is inhibited, potentially by an attached heme. The present investigation sought to determine if venoms derived from snakes of the Elapidae family (taipans and cobras) could also be inhibited with CO or with the metheme inducing agent, O-phenylhydroxylamine (PHA). Assessing changes in coagulation kinetics of human plasma with thrombelastography, venoms from Elapidae snakes were exposed in isolation to CO (five species) or PHA (one specie) and placed in human plasma to assess changes in procoagulant or anticoagulant activity. The procoagulant activity of two taipan venoms and anticoagulant activity of three cobra venoms were significantly inhibited by CO. The venom of the inland taipan was also inhibited by PHA. In sum, these data demonstrate indirectly that the biometal heme is likely bound to these disparate venoms as an intermediary modulatory molecule. In conclusion, CO may not just be a potential therapeutic agent to treat envenomation but also may be a potential modulator of heme as a protective mechanism for venomous snakes against injury from their own proteolytic venoms.

KW - Carbon monoxide

KW - Cobra

KW - Fibrinogenolysis

KW - Prothrombin activator

KW - Taipan

UR - http://www.scopus.com/inward/record.url?scp=85034747551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034747551&partnerID=8YFLogxK

U2 - 10.1007/s10534-017-0066-2

DO - 10.1007/s10534-017-0066-2

M3 - Article

C2 - 29170850

AN - SCOPUS:85034747551

SP - 1

EP - 9

JO - BioMetals

JF - BioMetals

SN - 0966-0844

ER -